Appears that impella ABMD is inserted into the heart.
SSH C-pulse is simpler; no heart blood contact.
ABMD and SSH do not seem to be competitors.
I've sold out my piggy on today's news.
Cash is going into someone else's piggy bank now; whomever bought those $1.80's.
The problem with such low specificity are the false positives that will have to get colonoscopies anyway, and the missed positives- the deadly cancers that will be missed by this "test."
I suggest you check out MELA. They had the same kind of results for their test, but for skin cancer.
FDA turned them down. But al least MELA is trying to go it alone w/o approval because their process keeps data about particular leisions. EXAS can't do this because EXAS process doesn't actually find polyps.
EXAS has little chance of getting FDA approval. Specificity not worth the cost.
Plus with current system of stool samples and a colonoscopy every 5 or ten years you get the same results but with a colonoscopy, the doc REMOVES the polyps DURING the colonoscopy.
EXAS is ame story as MELA a couple years ago.
Except the EXAS CEO can hype better than MELA's could.
Time to short this puppy to 0.
My bid is in at $4.88
But not likely until tomorrow unless the market gets more bad news today.
. . . And forward PE is 4.70!
Cost of gold production is $565 to $585 per oz.
ANV seems to be dropping for no good reason.
Well strenguy I guess you were right.
Now I'm waiting to buy back in. Maybe around $5.
With all this selling must be some big fund definitely wants out of HA. Can't fight the big guys.
How did you figure this out before it happened?
stren- You haven't made enough posts here to get the price any lower today.
You need to post a few more times. Also, try using all CAPS and shorting more.